EUROAPI CEO Karl Rotthier rings the bell at the Euronext exchange (Charlène Yves via EUROAPI)

De­fy­ing biotech bears, Sanofi man­u­fac­tur­ing spin­off surges on Paris de­but

Biotech stocks are be­ing mauled by a pro­tract­ed bear mar­ket while the Ukraine war casts a pall over Eu­rope, but that didn’t stop one Big …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.